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Abstract: We acquired images of breast malignancies using the Twente 
photoacoustic mammoscope (PAM), to obtain more information about the 
clinical feasibility and limitations of photoacoustic mammography. Results 
were compared with conventional imaging and histopathology. Ten 
technically acceptable measurements on patients with malignancies and two 
measurements on patients with cysts were performed. In the reconstructed 
volumes of all ten malignant lesions, a confined region with high contrast 
with respect to the background could be seen. In all malignant cases, the PA 
contrast of the abnormality was higher than the contrast on x-ray 
mammography. The PA contrast appeared to be independent of the 
mammographically estimated breast density and was absent in the case of 
cysts. Technological improvements to the instrument and further studies on 
less suspicious lesions are planned to further investigate the potential of 
PAM. 
© 2012 Optical Society of America 
OCIS codes: (110.5120) Photoacoustic imaging; (120.3890) Medical optics instrumentation; 
(170.1610) Clinical applications. 
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Introduction 
Breast cancer is one of the most common forms of cancer among females and worldwide each 
year more than 450,000 women are diagnosed with the disease [1]. Conventional breast 
imaging techniques, like x-ray mammography and ultrasonography, primarily focus on 
morphological changes of breast tissue to discriminate benign from malignant tissue. 
However, sensitivity and specificity numbers for both diagnostic x-ray mammography and 
ultrasonography do not often exceed 85% [2]. Moreover x-ray mammography uses ionizing 
radiation and is not reliable in women with dense breasts and ultrasonography is strongly 
operator dependent [2]. 
Tumor angiogenesis is a critical process in tumor growth and spread. In angiogenesis, new 
microscopic blood vessels are formed that feed proliferating tumor cells and thereby support 
unregulated tumor expansion [3, 4]. Therefore, tumor vascularization is a crucial feature to be 
included in breast imaging [4]. While various techniques for imaging breast cancer related 
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vascularization will be briefly discussed here, reference [5] provides a more complete 
overview. 
One commonly used method that focuses on tumor vascularization is Dynamic Contrast 
Enhanced MRI (DCE-MRI). The high sensitivity of this technique for detecting breast cancer 
proves that vascularity can indeed provide additional information about the nature of tissue 
[6]. However, DCE-MRI suffers from a limited specificity, requires the injection of contrast 
agents and is relatively expensive [6]. 
The application of far-red and near-infrared (NIR) light in (non-invasively) visualizing 
cancer and its associated vasculature is gaining attention due to its ability to provide 
functional and molecular information without the use of ionizing radiation. In recent studies, 
it has been shown that optical imaging in the form of diffuse optical tomography (DOT) can 
indeed visualize breast malignancies [7], primarily because of the high absorption of 
hemoglobin in the NIR regime. However, DOT suffers from low spatial resolution. At a few 
centimeters depth, the resolution lies in the range of 3 mm and it worsens with depth [8,9]. 
Several approaches are being investigated to improve the localization and resolution in DOT 
including using ultrasound guidance [10, 11], MRI [12] and x-ray mammography [13]. 
Photoacoustic imaging (PAI) also exploits the high NIR light absorption contrast between 
benign and malignant tissue, but provides superior resolution arising from ultrasound 
detection [14–17]. In photoacoustic imaging, nanoseconds pulsed laser light induces 
ultrasound transients due to the thermoelastic mechanism at optical absorbing sites. The 
pressure wave propagates to the surface where it is detected using wideband ultrasound 
detectors [14, 15, 18]. The amplitude of the photoacoustic signal depends on the amount of 
light absorbed in the object and the distance and material between the object and the detector; 
the time-of-flight and frequency content depend on the object’s position and size, 
respectively. The detected signal is not the highly scattered light, but the much less scattered 
ultrasound, and therefore the resolution of PAI is superior to that of pure optical techniques. 
In the last years, several groups have studied the feasibility of photoacoustics in breast 
imaging. Special instruments with different configurations have been developed to get the 
optimal resolution, imaging depth and contrast in breast tissue phantoms and healthy human 
subjects [19–26]. Also a few clinical studies have been performed exploring the feasibility of 
producing high-resolution clinical photoacoustic images arising from tumor vascularization 
[19, 27]. Our own group developed the Twente Photoacoustic Mammoscope (PAM), to image 
the breast in transmission mode [22, 28]. In a first pilot study with this system in 2007, it was 
possible to get technically acceptable measurements on five patients with radiographically 
proven breast malignancies. Of those, four cases revealed a high photoacoustic contrast with 
respect to the background associated with tumor related vasculature [27, 28]. 
We have recently started an extended clinical study using PAM, as a continuation of the 
study performed in 2007. In the new study, we want to investigate the clinical feasibility of 
photoacoustic mammography in a larger group of patients with different types of breast 
lesions. Here we describe the results of the first phase of our study. 
Materials and methods 
The ethical review board of the Medisch Spectrum Twente (MST) approved the study 
protocol and informed consent procedure. The study has been registered in the Netherlands 
Trial Register (NTR) as TC 2945. 
Patients 
Patients were included from the Center for Breast Care of the Medisch Spectrum Twente 
hospital in Oldenzaal based on the BI-RADS® (Breast Imaging Reporting and Data System 
[29]) classification of their lesion. Between December 2010 and April 2011, female patients 
with a palpable breast lesion that was judged as being highly suspicious for malignancy (BI-
RADS 5) on at least one of the conventional imaging modalities, were asked to participate to 
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the study. Additionally, a selected number of patients exhibiting signs of cysts (BI-RADS 2) 
were also included in the study. Inclusion criteria were: 1) age over 18 years and 2) the 
presence of a palpable BI-RADS 5 lesion or a cyst within an accessible region of the breast. 
Exclusion criteria were: 1) physical incapability to lie in a prone position for 30 minutes; 2) 
history of breast surgery or radiation therapy within a period of 5 years prior to this study; 3) 
history of breast biopsy within a period of 3 months prior to this study; and 4) incapability to 
give fully informed consent. All patients had to sign an informed consent form prior to the 
study. 
Diagnostic procedure 
All patients followed the normal diagnostic pathway at the center for breast care of the MST. 
A nurse practitioner performed clinical anamnesis and physical examination prior to 
conventional imaging. Cranio-caudal (cc) and medio-lateral-oblique (mlo) x-ray images of 
both breasts were made using the Lorad Selenia Full Field Digital Mammography System 
(Hologic, Bedford, USA). The breasts and axillas were also examined by a radiologist using a 
Philips IU22 ultrasound machine operating at 15 MHz (Philips Medical Systems, Best, The 
Netherlands). If the patient met the inclusion criteria and signed an informed consent form, 
she was measured using PAM in between the ultrasound examination and the ultrasound-
guided core needle biopsy. Patients exhibiting signs of cysts did not get a core needle biopsy 
following the photoacoustic investigation. If additional imaging information was required for 
a proper diagnosis or treatment planning, patients were scheduled for a pre-operative dynamic 
contrast enhanced MRI investigation. Both high-resolution, anatomic T2 weighted images and 
dynamic T1 weighted images before and after gadolinium injection were obtained using a 1.5 
Tesla MR system in combination with a 7 channel Sense Breast Coil (Philips Medical 
Systems, Best, The Netherlands). The x-ray, ultrasound and MRI images were interpreted by 
a breast imaging radiologist. This radiologist also estimated the lesion size on conventional 
imaging and the lesion depth on ultrasound imaging. 
The Twente photoacoustic mammoscope 
The Twente photoacoustic mammoscope (PAM, Fig. 1) is built into a hospital bed on which 
the patient has to lie in a prone position with her breast pendant through an aperture [22, 28]. 
The breast is slightly compressed between a glass plate at the cranial side and the ultrasound 
detector array at the caudal side. The breast is illuminated through the glass plate with light 
from a Q-switched Nd:YAG laser (Continuum Surelite, California) at 1064 nm with 10 ns 
pulses at a repetition rate of 10 Hz. The illuminating beam scans a rectangular region across 
the breast. The photoacoustic signals that are generated are detected with a 1 MHz (130% 
bandwidth) unfocused 2D ultrasound detector array (Lunar Corporation, General Electric, 
Wisconsin) with a diameter of 80 mm. The detector’s characteristics are described in detail 
elsewhere [28]. The photoacoustic signals are read into the PC on a dual channel digitizer 
(National Instruments, NI-5112, 100 MS/s, 8 bits). A Labview program (National 
Instruments) controls the scan stage movements and the element selection. 
Information from the x-ray mammograms and ultrasound images was used to define a 
region of interest (ROI) on the breast. The ROI was usually chosen in the range of 40x40 
mm2, being a trade-off between scan area and scan time. With this size of the ROI, the total 
measurement time was always kept shorter than 25 minutes. Uncolored ultrasound gel 
(Sonogel nr. 3010, Germany) was used for acoustic coupling between the breast and the 
detector. The breast was slightly compressed to ensure good contact with the detector. At the 
breast, the laser fluence in the 2.5 cm2 spot was kept at approximately 25 mJ/cm2. For each 
position of the light delivery system within the ROI, the opposite detector element was 
activated and an average was taken over signals generated by 90 subsequent laser pulses. 
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Fig. 1. The Twente photoacoustic mammoscope. a) Aperture to insert breast. b) Ultrasound 
detector matrix. c) Glass window. d) Scanning system compartment. e) Q-switched Nd-YAG 
laser operated at 1064 nm with 10 ns pulses. f) Laser safety curtain which is drawn around the 
instrument during the measurements. g) Interface electronics between detector and computer. 
h) Linear stage carrying detector matrix driven by hand wheel to apply mild compression to the 
breast. i) Laser remote control unit. j) Laser power supply. Image adapted from reference [27] 
with permission. 
 
The signal processing and image reconstruction was done with Matlab (R2009b, the 
Mathworks Company). The offset from all individual signals was removed off-line and the 
signals were filtered with a low pass Butterworth filter (cut-off frequency 5 MHz) to remove 
high frequency noise. The prominent breast surface signals were removed from the raw 
signals prior to reconstruction in order to have a more homogeneous dynamic range in the 
volume of interest. A modified acoustic backprojection algorithm was used to reconstruct the 
images. In this algorithm, the signals are back projected over spherical arcs onto their possible 
points of origin, taking into account the angular sensitivity of the elements [30, 31]. A 
homogeneous speed of sound (SOS) value of 1540 m/s was chosen for the breast. For the 
imaging configuration, maximum imaging depth and resolution (3.5 mm in both axial and 
lateral dimensions [22]) of PAM, the estimated [32] deterioration in resolution is not 
significant. 
After reconstruction, the separate slices were Hilbert transformed and all voxel intensity 
values were scaled to the maximum intensity value within the total volume, giving a range of 
intensity values between 0 and 255. 
Data analysis 
The reconstructed PAM image volumes were analyzed for the presence of confined regions 
with high intensity. A subvolume was defined as that stack of transverse slices which, on 
visual inspection, completely included a confined high intensity region. A threshold was 
chosen to be a percentage (usually 50%) of the maximum intensity value within this 
subvolume. The photoacoustic abnormality was subsequently defined as that region in which 
all voxel values exceeded this threshold. The contrast was defined as the ratio of the average 
intensity value within the abnormality and the average intensity value outside the abnormality. 
For each abnormality a maximum intensity projection (MIP) image was made. The size was 
defined as the maximum dimension of the abnormality measured on this MIP image. 
The presence, size and shape of the photoacoustic abnormalities was compared with the 
lesion’s appearance and size on conventional imaging as reported by specialized breast 
radiologists and, if applicable, with the histopathologically (H&E staining) assessed type and 
size of the lesion (gold standard). The radiologists estimated the depth of the lesion based on 
the ultrasound images. For each patient, the fibroglandular breast density was then estimated 
on the x-ray mammogram by a breast radiologist according to the BI-RADS breast density 
classification scale (Table 1 [29]). Moreover, the contrast of the lesion on x-ray 
mammography was estimated as the average intensity within an ROI in the malignancy 
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divided by the average intensity within an ROI in the background tissue. The breast density 
was compared with the lesion’s contrast seen on both the photoacoustic images and the x-ray 
mammograms. For both PAM and x-ray mammography, the contrast between the low and 
high density groups was tested for significant difference using a Student’s two-sample t-test. 
Table 1. BI-RADS breast density classification scale [29] 
 
Percentage glandular tissue Description 
BI-RADS density 1 < 25% The breast is almost entirely fat 
BI-RADS density 2 25-50% Scattered fibroglandular densities 
BI-RADS density 3 51-75% Heterogeneously dense breasts 
BI-RADS density 4 >75% Extremely dense breasts 
Results 
In the period December 2010 - April 2011, seventeen Caucasian patients were included in the 
study. Three patients could not be measured either because of discomfort while lying on the 
bed or because their lesion was difficult to access completely in the scan region. Of the 
remaining 14 cases, two were technically unacceptable due to poor acoustic contact between 
breast and detector in the ROI. Ten of the successful measurements were on highly suspect 
breasts carrying one or more BI-RADS 5 lesions and two were on breasts with cysts. Table 2 
shows an overview of the patients studied. 
Table 2. Overview of the patients measured in phase 1 of the study* 
The mammographic breast density is expressed as a BI-RADS classification (Table 1). IDC = Infiltrating Ductal 
Carcinoma and ILC = Infiltrating Lobular Carcinoma. The lesion size is estimated microscopically during 
histopathological investigation of the tissue specimen post-surgery, the lesion depth is estimated on the ultrasound 
(US) images as the shortest distance from the skin to the lesion. 
Patient Age (y) BI-RADS 
breast density 
Lesion type Lesion size  
(histopathology) 
Lesion depth 
(US) 
1 78 1 Mixed IDC, ILC 30 mm < 5 mm 
4 67 4 IDC 15 mm 10 mm 
5 55 3 ILC 42 mm 10 mm 
6 84 3 IDC 13 mm 10 mm 
7 57 1 Mixed IDC, ILC 27 mm 13 mm 
9 64 2 IDC 31 mm 10 mm 
10 49 4 IDC > 30 mm** < 5 mm 
11 43 4 Cyst 28 mm** 10 mm 
14 54 1 IDC > 40 mm** < 5 mm 
15 48 4 Cyst 42 mm** 5 mm 
16 71 2 IDC 33 mm 5 mm 
17 68 1 IDC 27 mm >30 mm 
* Only the patient information from the twelve technical acceptable measurements is shown here. 
** In patients 10-15, the lesion size was estimated radiologically, since there was no histopathological measurement 
available. 
In the following sections, the results of three representative patient measurements are 
discussed. 
Case 1 – infiltrating ductal carcinoma 
In this case, a 67 year old woman (patient 4 in Table 2 and 3) had a palpable lesion in the 
medial upper quadrant of her right breast. The x-ray image of this lesion is shown in Fig. 2(a). 
Based on the left-right asymmetry and the presence of a 20 mm lesion (white square) with a 
suspect calcification in this relatively dense breast tissue, the lesion was judged to be highly 
suspicious for malignancy (BI-RADS 5). The contrast of the lesion with respect to the fatty 
tissue was 2.6, while the contrast of the lesion with respect to the fibroglandular tissue was 
close to 1. The ultrasound image (Fig. 2(b)) showed a 17.5 mm hypoechoic lesion (arrow) 10 
mm below the skin. On ultrasound, the lesion was judged as being suspicious for malignancy 
(BI-RADS 4). 
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Transversal slices through the reconstructed photoacoustic volume at the expected lesion 
depth (Fig. 2(d)) showed the presence of a high-contrast region. Based on the photoacoustic 
MIP image, the maximum diameter of this abnormality was 10 mm when a 50% threshold 
was taken to define the abnormality. Figure 2(e) shows a schematic of the imaging planes of 
the different imaging modalities that are compared throughout this paper. Note that the x-ray, 
MRI and PAM images are all from the transverse plane; the MRI and PAM images are always 
rotated to match the orientation of the cranio-caudal x-ray image. 
After histopathological confirmation of the presence of an infiltrating ductal carcinoma 
(IDC), the patient was scheduled for a preoperative MRI. The T2 weighted MRI images 
showed relatively dense breast structures without cystic changes. T1 post-contrast images 
confirmed the presence of the malignancy medial in the right breast (white square) with a 
maximum diameter of 18 mm (Fig. 2(c)). The post-surgical histopathological assessment of 
the lesion revealed the presence of a 15 mm, grade 2 (on the Bloom-Richardson scale), 
infiltrating ductal carcinoma. 
 
Fig. 2. Case 1: Diagnostic images of a 15mm infiltrating ductal carcinoma in the right breast of 
a 67 year old woman. a) The cranio-caudal (cc) x-ray mammogram shows a 20 mm lesion with 
a calcification (white box) and is highly suspicious for malignancy. b) The ultrasound image 
shows a 17.5 mm hypoechoic lesion (arrow). c) The transverse view of the T1 weighted MRI 
after gadolinium injection confirms the presence of malignancy because of the enhancement of 
an 18 mm lesion (white box) in the medial upper quadrant of the right breast. This image is 
rotated to match the orientation of the cc x-ray view in Fig. 2(a). d) A transversal cross-section 
with a slice-thickness of 0.24 mm through the photoacoustic volume at the expected lesion 
location shows a confined region with high contrast with respect to the background. With the 
chosen threshold for abnormality definition, the contrast of the abnormality in the 3D volume 
is 6.4 and the maximum diameter is 10 mm. This image is rotated to match the orientation of 
the cc x-ray view in Fig. 2(a). e) The imaging planes of the different imaging modalities used 
in this paper. Indicated are the imaging planes for cranio-caudal x-ray mammography, 
transverse MRI, transverse PAM and a representative ultrasound view. Imaging planes for 
MRI, x-ray and PAM are comparable, but the region of interest of PAM is small compared to 
that of MRI and x-ray, which image the complete breast. The imaging plane of ultrasound is 
dependent on the position of the ultrasound probe. 
Case 2 – ductal carcinoma in situ with infiltrating foci 
This 64 year old woman (patient 9 in Table 2 and 3) arrived at the Center for Breast Care 
following a suspicious screening mammogram. A 50 mm smooth and mobile mass could be 
palpated in the lateral quadrant of the right breast, which was not directly suggestive for 
malignancy. The cranio-caudal x-ray image of this patient’s right breast (Fig. 3(a)) showed 
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atypical and suspicious microcalcifications in the lateral upper quadrant (white square). This 
area was assigned as BI-RADS 5. The ultrasound images (Fig. 3(b)) showed a large, 
inhomogeneous abnormality with calcifications in this same region at 9 o’clock (white 
square). In contrast to the mammogram, the ultrasound image was most suggestive for a 
benign fibroadenoma. The 30 mm large lesion was judged as BI-RADS 3 (probably benign 
lesion). Close to this lesion, a comparable, but smaller, lesion could be located (not visible in 
this image). 
The reconstructed photoacoustic volume (Figs. 3(d)-3(f)) showed two abnormalities, 
separated by less than 10 mm. The contrast and sizes of the lesions can be found in Table 3. 
Histopathological assessment of the biopsy revealed signs of ductal carcinoma in situ 
(DCIS) with focalized IDC. A preoperative MRI revealed an extended lobed lesion in the 
contrast-enhanced T1-weighted images of the right breast in the lateral quadrant (Fig. 3(c), 
white square). The lesion had a maximum diameter of 34 mm and showed a type 3 
enhancement pattern [33] (rapid increase of contrast enhancement with fast wash-out), 
corresponding to the presence of an infiltrating carcinoma. Caudal to this lesion (not seen in 
this image) and also in the lateral part of the breast, there was a second lobed lesion with a 
maximum diameter of 14 mm and also a type 3 enhancement pattern. 
Post-surgical histopathological investigation of the breast, revealed the presence of a 31 
mm grade 3 IDC growing in irregular fields and associated with extensive DCIS. The two 
lesions that could be seen on photoacoustic imaging, MRI and US, probably represented two 
invasive foci of this large abnormal region. 
 
Fig. 3. Case 2: Diagnostic images of a 31 mm infiltrating ductal carcinoma in the right breast 
of a 64 year old woman. a) The cranio-caudal mammogram of the right breast shows a large 
region with atypical and suspicious microcalcifications (white square). b) The ultrasound 
image shows a large inhomogeneous lobed mass (white square) with microcalcifications, 
which is somewhat suggestive for a benign fibroadenoma. Close to this large lesion, there is a 
second comparable, but smaller lesion (not visible in this image). c) The T1 weighted contrast 
enhanced MRI shows two lesions in the lateral quadrant of the right breast. The biggest lesion 
(white square) is visible in this image and measures 34 mm, the second, smaller lesion (14 
mm) is positioned caudal to this lesion and is not visualized here. d) Photoacoustic imaging 
also shows two abnormalities, separated less than 10 mm. e) The upper abnormality (5 mm 
depth) has a contrast of 4.7 and a maximum diameter of 26 mm and can be seen in this 
transversal cross-section (slice thickness 0.24 mm). f) The smaller, lower (13 mm depth) 
abnormality had a contrast of 5.3 and a maximum diameter of 14 mm. 
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Case 3 – mixed infiltrating lobular and ductal carcinoma 
This 78 year old woman (patient 1 in Table 2 and 3) had a palpable mass behind the nipple of 
her left breast. Visual inspection showed reddening and thickening of the skin close to the 
nipple. On palpation a 20 mm palpable mass could be felt behind this lesion. On x-ray 
mammography (Fig. 4(a)), the breasts were relatively transparent, but there was a clear left-
right asymmetry. Behind the nipple (green square) of the left breast, a region of dense breast 
tissue (blue-dashed square, lesion 1), associated with some microcalcifications, was 
identified; this was most likely the palpable lesion. In addition, there was a density close to 
the nipple (white square, lesion 2), likely the lesion observed on visual inspection. The two 
lesions were assigned as BI-RADS 4 and BI-RADS 5, respectively. On ultrasound (Fig. 4(b)) 
only one lesion could be identified: an oval-shaped lesion in the skin just above the nipple 
(white square). The diameter of this lesion was 18 mm and the lesion was assigned as a BI-
RADS 5 lesion. In the remainder of the breast, there were no signs for malignancy. 
For photoacoustic imaging, the breast required support by a block and slight tilting to 
achieve good contact with the detector at the ROI. In contrast to other measurements, the 
surface signal was not removed before reconstruction, since the most suspicious lesion was 
positioned close to the breast surface. In Figs. 4(c) and 4(d), two transversal slices through the 
reconstructed photoacoustic volume are shown. Near the surface a 14 mm abnormality could 
be observed (Fig. 4(c), white square). In depth, this abnormality was connected to a second 
abnormality (Fig. 4(d), blue-dashed square). A third region could also be observed at this 
depth (Fig. 4(d), green-dotted square). We hypothesize that the photoacoustic images show 
one malignant lesion with a component close to the skin (Fig. 4(c), white square) and a deeper 
component (Fig. 4(d), blue-dashed square). Please note that by x-ray mammography only two 
separate lesions and by ultrasonography only one superficial lesion could be observed. The 
macroscopic and microscopic investigation of the tissue specimen after mastectomy showed 
indeed one 36 mm, grade 2, mixed infiltrating ductal and lobular carcinoma (mixed IDC and 
ILC), which was almost attached to the skin of the nipple. 
 
Fig. 4. Case 3: Diagnostic images of a mixed infiltrating ductal and lobular carcinoma in the 
left breast of a 78 year old woman. a) The medio-lateral-oblique x-ray mammogram shows two 
lesions: a lesion of dense breast tissue (blue-dashed, lesion 1) which is associated with some 
microcalcifications and is positioned behind the nipple (green dotted square). The second 
lesion, indicated by a white box, is a density close to the skin of the nipple. b) The ultrasound 
images only show one oval-shaped lesion in the skin just above the nipple (white box). c) 
Transversal cross-sections (slice thickness 0.24 mm) through the photoacoustic image volume 
show a very superficial 14 mm abnormality (white box), which is attached to the skin and 
which is in depth connected to d) a 15 mm abnormality (blue-dashed square) with a contrast of 
more than 3 with respect to the background. In this cross-section a third region with high 
contrast could be observed (green-dotted square), which probably represents the nipple. The 
circular artifacts that are visible in Figs. 4(c) and 4(d) are inherent to the backprojection 
algorithm. These artifacts are more pronounced close to the surface as are these slices. 
Based on its position in the image, the third region (Fig. 4(d), green-dotted square) was 
thought to represent the nipple-areola complex. It is known that the nipple-areolar complex 
also shows contrast enhancement on MRI [34, 35]. This is probably caused by the vascular 
branches from variable main arteries that supply the nipple-areola complex with blood and 
nutrients [36]. Therefore, it is plausible that this area is also visible with PAM. Moreover, the 
#161771 - $15.00 USD Received 18 Jan 2012; revised 21 Mar 2012; accepted 29 Mar 2012; published 7 May 2012
(C) 2012 OSA 21 May 2012 / Vol. 20,  No. 11 / OPTICS EXPRESS  11591
  
increased skin pigmentation of the nipple and areola might also absorb the 1064 nm light and 
thereby contribute to increased signals. To test this hypothesis, the measuring configuration 
and breast positioning as in patient 1 were repeated with a healthy volunteer. The resulting 
photoacoustic image (Fig. 5) showed a region of high absorption, highly comparable to the 
supposed nipple in Fig. 4(d). 
 
Fig. 5. The photoacoustic image of a healthy volunteer, measured in the same configuration as 
patient 1. This image shows a transversal cross-section at the position of the nipple. The 
identified region with high-contrast is quite comparable to the region that was hypothesized to 
represent the nipple in case 3 (Fig. 4(d), green-dotted square). 
Overall results 
In the reconstructed volumes of all ten measurements on BI-RADS 5 lesions, a confined 
region with high contrast with respect to the background could be seen at the depth where the 
lesion was expected based on the ultrasound images. However, in some patients (patients 5, 6 
and 17) this region was at the border of the scan because of slight mispositioning. Incorrect 
positioning was caused by the limited size of the region of interest. In those patients, the size 
of the abnormality on the photoacoustic mammogram could not fully be estimated. Table 3 
provides an overview of the identified photoacoustic abnormalities with their contrast and 
size. For comparison, Table 3 also shows the contrast of the lesions on the cranio-caudal x-ray 
mammograms, and the histopathologically assessed size of the lesions, which is the gold 
standard for lesion size estimation. 
Table 3. Measurement results from photoacoustic mammography 
Lesions as defined on the photoacoustic images are compared with x-ray mammography and histopathology, based 
on contrast and maximum diameter respectively. 
 
Patient PAM lesion visibility 
(positive contrast) 
PAM lesion 
contrast 
 
X-ray lesion 
contrast 
PAM max. 
diameter (50% 
threshold) 
Lesion size 
(histopathology) 
1 Yes 3.2 1.6-4.7** 24 mm 30 mm 
4 Yes 6.4 1 −2.6** 10 mm 15 mm 
5 Yes 3.3 1.9 *** 42 mm 
6 Yes 6.2 1.0 *** 13 mm 
7 Yes 5.3 2.6 14 mm 27 mm 
9 Yes,  
Two lesions 
1) 5.3 
2) 4.7 
3.5 1) 14 mm 
2) 26 mm 
31 mm 
10 Yes 4.5 1.2 13 mm > 30 mm* 
11 No 1.0 1.0 Not visible 28 mm* 
14 Yes, scattered 
abnormality 
4.0 3.8 Scattered > 40 mm* 
15 No 1.0 1.0 Not visible 42 mm* 
16 Yes. 7.0 3.4 9 mm 33 mm 
17 Yes 4.9 1.3 *** 27 mm 
*In patients 10-15, the lesion size was estimated radiologically, since there was no histopathological measurement 
available. **These lesions were positioned partly in fatty tissue and partly in fibroglandular tissue. Therefore, the 
contrast for these lesions on x-ray mammography is given with respect to both types of background. *** In these 
measurements the defined lesion was only partly positioned within the region of interest and the maximum diameter 
could not be assessed. 
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The two reconstructed volumes of the photoacoustic measurements on cysts (patients 11 
and 15) manifested no such confined high-contrast regions which extend over multiple slices 
in depth. Figure 6(a) shows the photoacoustic imaging results of a 44 year old patient with a 
cyst (patient 11). On ultrasonography the cyst was estimated to be positioned at more than 10 
mm in depth and to measure about 28 mm in diameter. Figure 6(a) shows the non-normalized 
MIP of the photoacoustic imaging volume in the depth range where the cyst was expected. 
For comparison, Fig. 6(b) shows a non-normalized MIP from a photoacoustic measurement 
on a malignancy which was positioned at comparable depth as the cyst. The confined high-
contrast area which can clearly be seen in Fig. 6(b) is absent in Fig. 6(a). Despite the fact that 
both MIPs are taken over the same depth range, the absolute intensity values are lower for the 
measurement on the cyst than for the measurement on the malignancy. 
 
Fig. 6. a) Maximum intensity projection (MIP) in cranio-caudal direction of the photoacoustic 
volume of a patient with a 25 mm cyst. No confined, homogeneous, high-contrast region can 
be seen. The higher intensities are spread over the complete region of interest. The intensity 
values are not normalized in this image. b) For comparison, a MIP in cranio-caudal direction of 
the photoacoustic volume of a patient with a malignancy (patient 4, Fig. 2) is visualized. The 
malignancy is located at a comparable depth as the cyst from Fig. 6(a) and the MIP is taken 
over the same depth-range. Here a confined high-contrast region can be seen. In the cyst, the 
non-normalized intensity values are much lower than in the malignancy, despite the fact that 
the MIPS are from the same depth. 
The average contrast for the visible lesions on x-ray mammography and PAM is shown 
per BI-RADS breast density category in Fig. 7(a). It can be seen that the contrast on PAM is 
fairly constant with breast density, while the contrast on x-ray mammography decreases for 
denser breasts. This is more pronounced when a division into two density categories is made 
(Fig. 7(b)), which is the most reproducible way of grading breast density [37]. The contrast of 
the lesion on x-ray is statistically different (p<0.05) between the high and low density breasts, 
while there is no statistical difference in the contrast of the lesions on PAM. 
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Fig. 7. a) Per BI-RADS density classification scale, the average contrast of the lesions on PAM 
(gray) and x-ray mammography (white) is given. b) Here, only a differentiation between ‘low’ 
(BI-RADS density 1, 2) and ‘high’ (BI-RADS density 3, 4) breast density is made. The error 
bars show the plus and minus one standard deviation. When the lesion was positioned partly in 
fatty and partly in glandular tissue on the x-ray mammogram (patients 1 and 4), the contrast 
with respect to the fatty tissue was chosen, which always was the highest contrast. 
Discussion 
In this study we showed that NIR photoacoustic imaging as embodied in the Twente 
Photoacoustic Mammoscope (PAM) visualized breast malignancies in women with a high 
imaging contrast, while cysts did not manifest such confined high-contrast regions. 
Furthermore, the PAM determined contrast seems to be independent of mammographic breast 
density. However, PAM determined lesion size seems to be smaller than the histologically 
determined tumor sizes. Here, we critically discuss the results in the context of instrumental 
characteristics and limitations. 
Contrast and wavelength 
Light at 1064 nm is suitable for photoacoustic breast imaging: absorption and scattering are 
generally lower than at other wavelengths in the optical window, so that light can penetrate 
deep in breast tissue. Hemoglobin, primarily in its oxygenated variant, absorbs light at 1064 
nm [38] and therefore, contrast between healthy and malignant breast tissue is still expected 
because of the angiogenesis related increase in hemoglobin concentration. 
In all ten malignancies, PAM was able to visualize a confined high-contrast region at the 
true lesion depth and in all cases, the contrast was higher than observed on x-ray 
mammography. On average, the contrast of the abnormalities on PAM was 5, while the 
lesions could be seen on x-ray mammography with an average contrast of less than 3. This 
presence of confined high-contrast regions in photoacoustic images (Figs. 2-4) of 
malignancies, points to the visualization of the optical properties associated with carcinoma. It 
is most likely that we are observing, via the absorption of primarily oxyhemoglobin, the host 
tissue response in the form of angiogenesis [3, 4, 38, 39]. The contrast in our photoacoustic 
images seems not to be affected by the fibroglandular breast density (see Fig. 7), unlike in x-
ray mammography [2]. This can be explained by the expectation that neither the total 
hemoglobin concentration nor the oxygen saturation is significantly different between the four 
BI-RADS breast density scales [40]. 
The appearance of the rather homogeneous high-contrast regions is difficult to attribute 
solely to oxyhemoglobin, since it is known that the tumor vascularization is inhomogeneous 
and often more pronounced in the peripheral areas [41]. In addition to oxyhemoglobin at 1064 
nm, other important tissue constituents also absorb at this wavelength: water absorption is not 
low [42] and absorption by lipids and collagen is also not negligible [14, 38, 43]. While the 
fat content in cancerous tissue is decreased [44, 45], the (free) water concentration is 
significantly increased in invasive carcinoma compared to the surrounding normal breast 
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tissue [45, 46]. A contribution from water absorption to the photoacoustic image intensity 
cannot be excluded. 
Our results indicate that the contribution of water to the photoacoustic contrast is probably 
small with respect to the contribution of hemoglobin. First, if water was the prominent source 
of our photoacoustic contrast for breast carcinoma, we would also expect to see high contrast 
regions in the photoacoustic images of cysts which primarily consist of water. Because of the 
limited bandwidth of the transducer, the cysts would probably appear edge-enhanced. Though 
measurements on cysts have to be performed in a larger study population, the two 
measurements on cysts measured in the first phase of the study manifest no such features (Fig. 
6). Second, we would expect to see a decrease in photoacoustic contrast for the higher density 
breasts as these are associated with a significant increase in water concentration of the 
background tissue [40, 47]. In our results, the photoacoustic contrast seems to be independent 
of the breast density instead. 
It is therefore likely that the high photoacoustic contrast is the consequence of the 
combined absorption of predominantly hemoglobin with minor contribution of water in the 
extracellular tissue matrix. Further research to the specific contributions of all chromophores 
is required for an optimal discrimination between benign and malignant breast lesions. 
Size and shape 
The size and shape of the abnormalities estimated from photoacoustic images, deviated from 
that on conventional imaging and histopathological assessment. There are several factors that 
can influence the abnormality’s appearance. 
First, deviations can be the consequence of breast positioning and the amount of 
compression applied, both are varying between the different imaging modalities. Second, the 
level of the threshold strongly influences the estimation of the lesion’s extension. In Fig. 8 it 
can, for example, be seen that the lesion’s maximum diameter increases from 8 to 20 mm 
when the threshold decreases from 60% to 20%. Future evaluations in a large number of 
patients have to be performed to assess the optimal threshold for precise estimation of the true 
lesion size. 
 
Fig. 8. Transversal cross-section through the photoacoustic mammogram of patient 4 (see Fig. 
2). The lesion is defined with the help of three different thresholds, which are all expressed as a 
percentage of the maximum intensity value (red = 60%, blue = 40% and green = 20%). The 
value of the threshold strongly influences the maximum diameter of the defined lesion. In this 
case, the diameter of the lesion is estimated as being 8, 12 and 20 mm for the 60, 40 and 20% 
threshold respectively. 
Further, the planar imaging geometry provides limited views or incomplete tomographic 
projections for accurate reconstruction of especially size and shape of an abnormality [48, 49]. 
The viewing angle is further reduced since we consciously make a trade-off between scan 
area and scan duration in favor of shorter scan duration. 
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Finally, what we visualize in our images is not an absolute absorption coefficient, rather 
the absorbed light energy distribution. Images we obtain are thus affected with depth-
dependent falloff in contrast due to optical attenuation. Keeping a constant threshold for 
boundary estimation in depth can lead to an underestimation of lesion size as observed. A 
ground truth image contrast distribution and a minimization in the size estimation error can be 
achieved by using for example a forward model of light transport with iteratively corrected 
optical properties, that converges to match the reconstructed photoacoustic distribution [50, 
51]. 
Surface signal 
Due to the relatively high fluence at the breast surface, a large photoacoustic signal from the 
surface is present for all signals in the ROI. Therefore, removal of the photoacoustic surface 
signal from the remainder of the breast signal before the reconstruction is applied, is 
important. However, sometimes the skin signal cannot clearly be distinguished from the 
interior signal, especially since the detector has limited bandwidth. Moreover, the optical 
absorption of the skin, and therefore the resulting photoacoustic signals, can vary between 
different skin types. An incorrect removal of the surface signal could introduce size and shape 
errors for tumors close to the skin. This problem makes photoacoustic imaging in 
transmission mode with a limited bandwidth detector a challenge for superficial tumors (such 
as in case 3). Imaging in dark-field where the light delivery is not in the direction of 
ultrasound detection, or imaging in multiple views, would probably overcome this problem. 
Outlook 
Photoacoustic imaging allows for the visualization of breast malignancies without the use of 
ionizing radiation as in x-ray mammography or external contrast agents as in contrast 
enhanced MRI. The images can be obtained with the patient in a comfortable prone position 
with only minor breast compression. This study also showed some possibilities for 
improvement of the Twente Photoacoustic Mammoscope in its current configuration. 
The photoacoustic contrast at 1064 nm is possibly the consequence of the combined 
absorption of hemoglobin and water. However, also the fat content, the fat/water ratio and the 
oxygen saturation are known to be altered at malignant areas [46, 52]. Moreover, 
premalignant lesions like DCIS, and benign lesions like fibroadenoma seem to be associated 
with an increased blood volume fraction and water content respectively [46, 53].Those lesions 
might be differentiated from invasive carcinoma based on the concentrations of other 
chromophores and the oxygen saturation. The use of multiwavelength strategies will facilitate 
discrimination between various chromophores [54], which could help in discriminating 
malignant lesions from premalignant and benign lesions. 
In this study we mainly included Caucasian patients with lesions that were highly 
suspicious for malignancy on conventional imaging. Moreover, our system only allowed us to 
measure palpable lesions in certain regions of the breast. At last, the small region of interest 
we can measure within an acceptable time makes positioning difficult and can cause size and 
shape deviations in the reconstructed volume. Those problems can be overcome by increasing 
the measurement speed. 
PAM can visualize breast lesions with high contrast with respect to the background, but in 
order to estimate the discriminative power and clinical significance of photoacoustic breast 
imaging, we should gradually focus on less suspicious lesions, benign lesions and normal 
breasts with the aforementioned technical improvements. 
Conclusions 
The current study demonstrates the potential value of photoacoustic imaging of breast tumors. 
Photoacoustic images showed the lesions with a higher contrast than with x-ray 
mammography, while cysts did not induce such confined photoacoustic contrast. The 
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technique has several advantages over conventional modalities. The method neither uses 
ionizing radiation, nor contrast agents and seems not to be affected by the fibroglandular 
breast density. If the measurement speed were increased and complete 3D breast imaging 
were possible, the added value of photoacoustic imaging in breast diagnosis could be 
investigated. It is expected that even better contrasts and imaging depths would be obtained 
with the optimal choice of wavelengths and change of the image configuration. 
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